RA Capital Healthcare Fund LP's Form 4/A amendment
AmendedWave Life Sciences, Inc. (WVE) · filed Jan 17, 2024
- Accession no.
- 0001104659-24-004581
- Filed
- Jan 17, 2024, 7:06 PM ET
- Trade date
- Dec 11, 2023
- Filing delay
- 37 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Dec 13, 2023
This filing lists 1 non-derivative transaction. Open-market purchases total $5.00M. It was filed 37 days after the trade.
This amendment replaces 0001104659-23-125724 (filed Dec 13, 2023).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| RA Capital Healthcare Fund LPCIK 0001315082 | Director, 10% Owner |
| Ra Capital Management, L.P.CIK 0001346824 | Director, 10% Owner |
| Kolchinsky PeterCIK 0001384859 | Director, 10% Owner |
| Shah Rajeev M.CIK 0001619841 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2023 | Common Stock | PPurchaseAcquired | +1,000,000 | $5.00F1 | +$5,000,000 | 18,202,009 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Acquired from the Issuer pursuant to the public offering described in the Issuer's Prospectus filed with the Securities and Exchange Commission on December 8, 2023.
Referenced by the price of 1 transaction in Table I.
- F2
Held directly by RA Capital Healthcare Fund, L.P. (the "Fund").
- F3
RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.
- F4
This amendment is being filed solely to rectify a clerical error in column 5 which reflected a total shares held as 19,202,009 where it should have read 18,202,009.
Remarks
Dr. Peter Kolchinsky, a Managing Partner of the Adviser, serves on the Issuer's board of directors.